Therapeutic role of mTOR inhibitors in control of SARS-CoV-2 viral replication
Open Access
- 20 December 2022
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (3) , 2701-2711
Abstract
By the end of 2019, COVID-19 was reported in Wuhan city of China, and through human-human transmission, this virus spread worldwide and became a pandemic. Initial symptoms of the disease include fever, cough, loss of smell, taste, and shortness of breath, but a decrease in the oxygen levels in the body leads, and pneumonia may ultimately lead to the patient’s death. However, the symptoms vary from patient to patient. To understand COVID-19 disease pathogenesis, researchers have tried to understand the cellular pathways that could be targeted to suppress viral replication. Thus, this article reviews the markers that could be targeted to inhibit viral replication by inhibiting the translational initiation complex/regulatory kinases and upregulating host autophagic flux that may lead to a reduction in the viral load. The article also highlights that mTOR inhibitors may act as potential inhibitors of viral replication. mTOR inhibitors such as metformin may inhibit the interaction of SARS-CoV-2 Nsp’s and ORFs with mTORC1, LARP1, and 4E-BP. They may also increase autophagic flux by decreasing protein degradation via inhibition of Skp2, further promoting viral cell death. These events result in cell cycle arrest at G1 by p27, ultimately causing cell death. Graphical AbstractKeywords
This publication has 69 references indexed in Scilit:
- Skp2 is a Promising Therapeutic Target in Breast CancerFrontiers in Oncology, 2012
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like ParticlesJournal of Virology, 2008
- The SARS-CoV nucleocapsid protein: A protein with multifarious activitiesInfection, Genetics and Evolution, 2008
- Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancerNature Reviews Cancer, 2008
- Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2AJournal of Virology, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Efficient assembly and release of SARS coronavirus‐like particles by a heterologous expression systemFEBS Letters, 2004
- Heterologous Gene Expression from Transmissible Gastroenteritis Virus Replicon ParticlesJournal of Virology, 2002
- Differential in vitro inhibition of feline enteric coronavirus and feline infectious peritonitis virus by actinomycin DJournal of General Virology, 1992